Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells

ConclusionsThese results indicate that CD3+ cells from leukemic patients are capable of generating anti-leukemic responses when stimulated with unrelated allogeneic cells. This model can be used to identify approaches using alloreactive responses by patient lymphocytes to enhance in vivo anti-leukemic responses.
Source: Experimental Hematology and Oncology - Category: Cancer & Oncology Source Type: research